Gastrointestinal Endoscopy
Volume 66, Issue 3 , Pages 530-532 , September 2007

Recognition and appropriate management of dysplasia-associated lesions or masses in inflammatory bowel disease—experience does matter

References 

  1. Baumgart DC, Sandborn WJ. Inflammatory bowel disease: clinical aspects, established and evolving therapies. Lancet. 2007;369:1641–1657
  2. Bernstein CN, Blanchard JF, Kliewer E, et al. Cancer risk in patients with inflammatory bowel disease: a population-based study. Cancer. 2001;91:854–862
  3. Loftus EV, Harewood GC, Loftus CG, et al. PSC-IBD: a unique form of inflammatory bowel disease associated with primary sclerosing cholangitis. Gut. 2005;54:91–96
  4. Jess T, Loftus EV, Velayos FS, et al. Risk of intestinal cancer in inflammatory bowel disease: a population-based study from olmsted county, Minnesota. Gastroenterology. 2006;130:1039–1046
  5. Palascak-Juif V, Bouvier AM, Cosnes J, et al. Small bowel adenocarcinoma in patients with Crohn's disease compared with small bowel adenocarcinoma de novo. Inflamm Bowel Dis. 2005;11:828–832
  6. Carter MJ, Lobo AJ, Travis SP. Guidelines for the management of inflammatory bowel disease in adults. Gut. 2004;53(5 Suppl):V1-16
  7. Itzkowitz SH, Present DH. Consensus conference: colorectal cancer screening and surveillance in inflammatory bowel disease. Inflamm Bowel Dis. 2005;11:314–321
  8. Collins PD, Mpofu C, Watson AJ, et al. Strategies for detecting colon cancer and/or dysplasia in patients with inflammatory bowel disease. Cochrane Database Syst Rev. 2006;CD000279
  9. Farraye FA, Waye JD, Moscandrew M, et al. Variability in the diagnosis and management of adenoma-like and non-adenoma-like dysplasia-associated lesions or masses in inflammatory bowel disease: an Internet-based study. Gastrointest Endosc. 2007;66:519–529
  10. National Transportation Safety Board. Update on the Cirrus plane crash in Manhattan, New York. Available at http://ntsb.gov/Pressrel/2006/061103.htm. Accessed Dec 26, 2006.
  11. Singh H, Turner D, Xue L, et al. Risk of developing colorectal cancer following a negative colonoscopy examination: evidence for a 10-year interval between colonoscopies. JAMA. 2006;295:2366–2373
  12. Lieberman D. A call to action—measuring the quality of colonoscopy. N Engl J Med. 2006;355:2588–2589
  13. Winawer SJ, Zauber AG, Fletcher RH, et al. Guidelines for colonoscopy surveillance after polypectomy: a consensus update by the US Multi-Society Task Force on Colorectal Cancer and the American Cancer Society. CA Cancer J Clin. 2006;56:143–159
  14. Rex DK, Petrini JL, Baron TH, et al. Quality indicators for colonoscopy. Gastrointest Endosc. 2006;63(Suppl):S16–S28
  15. Barclay RL, Vicari JJ, Doughty AS, et al. Colonoscopic withdrawal times and adenoma detection during screening colonoscopy. N Engl J Med. 2006;355:2533–2541
  16. Baumgart DC. Personal digital assistants in health care: experienced clinicians in the palm of your hand?. Lancet. 2005;366:1210–1222

PII: S0016-5107(07)00224-6

doi: 10.1016/j.gie.2007.02.006

Gastrointestinal Endoscopy
Volume 66, Issue 3 , Pages 530-532 , September 2007

Article Tools